DK1635792T3 - Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivater - Google Patents
Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivaterInfo
- Publication number
- DK1635792T3 DK1635792T3 DK04756130T DK04756130T DK1635792T3 DK 1635792 T3 DK1635792 T3 DK 1635792T3 DK 04756130 T DK04756130 T DK 04756130T DK 04756130 T DK04756130 T DK 04756130T DK 1635792 T3 DK1635792 T3 DK 1635792T3
- Authority
- DK
- Denmark
- Prior art keywords
- aza
- bicyclo
- octane
- carboxylic acid
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 239000000314 lubricant Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- OQHKEWIEKYQINX-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrol-1-ium-2-carboxylate Chemical class C1CCC2NC(C(=O)O)CC21 OQHKEWIEKYQINX-UHFFFAOYSA-N 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000007892 solid unit dosage form Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48251803P | 2003-06-26 | 2003-06-26 | |
| PCT/US2004/020484 WO2005002548A1 (en) | 2003-06-26 | 2004-06-24 | Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1635792T3 true DK1635792T3 (da) | 2009-06-15 |
Family
ID=33563864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04756130T DK1635792T3 (da) | 2003-06-26 | 2004-06-24 | Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivater |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20050069586A1 (de) |
| EP (1) | EP1635792B1 (de) |
| AT (1) | ATE424192T1 (de) |
| CA (1) | CA2530788C (de) |
| DE (1) | DE602004019777D1 (de) |
| DK (1) | DK1635792T3 (de) |
| ES (1) | ES2322854T3 (de) |
| IL (1) | IL172602A0 (de) |
| MX (1) | MXPA06000226A (de) |
| PL (1) | PL1635792T3 (de) |
| PT (1) | PT1635792E (de) |
| WO (1) | WO2005002548A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2530788C (en) * | 2003-06-26 | 2010-02-09 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| US20050095287A1 (en) * | 2003-10-29 | 2005-05-05 | Matharu Amol S. | Fosinopril composition |
| WO2005067887A2 (en) * | 2004-03-24 | 2005-07-28 | Actavis Group | Formulations of ramipril |
| PT1729739T (pt) * | 2004-03-29 | 2016-12-01 | Servier Lab | Processo para a preparação de uma composição farmacêutica sólida |
| WO2006052968A2 (en) * | 2004-11-05 | 2006-05-18 | King Pharmaceuticals Research & Development, Inc. | Stabilized ramipril compositions and methods of making |
| GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
| GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
| US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
| WO2007120930A2 (en) * | 2006-04-19 | 2007-10-25 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| WO2008132756A1 (en) * | 2007-05-01 | 2008-11-06 | Lupin Limited | Stable pharmaceutical compositions of ramipril |
| TR200906322A2 (tr) | 2009-08-17 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. |
| EA028950B1 (ru) * | 2011-08-01 | 2018-01-31 | Тева Фармасьютикал Индастриз Лтд. | Способ получения фармацевтических композиций, содержащих финголимод |
| BR112014020184B1 (pt) | 2012-02-17 | 2021-11-30 | Egis Gyógyszergyár Zrt | Preparação farmacêutica que contém anlodipina e ra-mipril |
| HUP1300496A2 (hu) | 2013-08-16 | 2015-03-02 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Stabil kombinációs gyógyszerkészítmény |
| EP3275432A1 (de) * | 2016-07-25 | 2018-01-31 | H e x a l Aktiengesellschaft | Darreichungsform mit ace-hemmer |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2812314A (en) * | 1952-08-23 | 1957-11-05 | Monsanto Chemicals | Calcium and alkali metal double salts of hydrolyzed polyacrylonitrile |
| US2812344A (en) * | 1956-02-13 | 1957-11-05 | Ortho Pharma Corp | Ferrous calcium citrate complex |
| ZA817261B (en) * | 1980-10-23 | 1982-09-29 | Schering Corp | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them |
| DE3226768A1 (de) * | 1981-11-05 | 1983-05-26 | Hoechst Ag, 6230 Frankfurt | Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung |
| US4793998A (en) * | 1986-10-20 | 1988-12-27 | Warner-Lambert Company | Stabilized drug compositions |
| US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| US5054483A (en) * | 1989-03-06 | 1991-10-08 | Hood Laboratories | Tracheal cannulas and stents |
| US4973470A (en) * | 1989-06-26 | 1990-11-27 | Warner-Lambert Company | Sustained release pharmaceutical compositions |
| US5006344A (en) * | 1989-07-10 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Fosinopril tablet formulations |
| DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
| TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
| EP1083931B1 (de) * | 1998-06-05 | 2005-05-11 | Warner-Lambert Company LLC | Stabilisierung von zusammensetzungen enthaltend ace-hemmer durch magnesiumoxid |
| US6555551B1 (en) * | 1999-08-31 | 2003-04-29 | Mutual Pharmaceutical Co., Inc. | Stable formulations of ACE inhibitors, and methods for preparation thereof |
| US6979462B1 (en) * | 2000-10-03 | 2005-12-27 | Mutual Pharmaceutical Co., Inc. | Stabilization of solid drug formulations |
| CA2330904C (en) * | 2001-01-11 | 2006-10-24 | Bernard Charles Sherman | Fosinopril sodium tablet formulation |
| US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| IS1935B (is) * | 2002-03-19 | 2004-06-16 | Actavis Group Hf. | Fósínópríl lyfjasamsetning |
| EP1501546B1 (de) * | 2002-05-03 | 2012-10-10 | Hexal AG | Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer |
| TW200306799A (en) * | 2002-05-17 | 2003-12-01 | Novartis Ag | Combination of organic compounds |
| AR039744A1 (es) * | 2002-06-26 | 2005-03-09 | Alza Corp | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada |
| CA2530788C (en) * | 2003-06-26 | 2010-02-09 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| US6869963B2 (en) * | 2003-07-11 | 2005-03-22 | Sandoz Ag | Stable pharmaceutical compositions containing an ACE inhibitor |
| US20050181055A1 (en) * | 2003-10-08 | 2005-08-18 | Mathur Rajeev S. | Pharmaceutical compositions of quinapril |
| US20050095287A1 (en) * | 2003-10-29 | 2005-05-05 | Matharu Amol S. | Fosinopril composition |
| US20050256056A1 (en) * | 2003-12-05 | 2005-11-17 | The Regents Of The University Of California Office Of Technology Transfer University Of California | Peptide inhibitors of HIV |
| US20060045911A1 (en) * | 2004-08-27 | 2006-03-02 | Sun Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations |
| WO2006052968A2 (en) * | 2004-11-05 | 2006-05-18 | King Pharmaceuticals Research & Development, Inc. | Stabilized ramipril compositions and methods of making |
| US20070009591A1 (en) * | 2005-07-07 | 2007-01-11 | Trivedi Jay S | ACE inhibitor formulation |
| GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
| US20070116762A1 (en) * | 2005-11-07 | 2007-05-24 | Wilson Edward S | Compositions of stabilized ramipril in combination with another active agent |
-
2004
- 2004-06-24 CA CA2530788A patent/CA2530788C/en not_active Expired - Fee Related
- 2004-06-24 MX MXPA06000226A patent/MXPA06000226A/es active IP Right Grant
- 2004-06-24 PL PL04756130T patent/PL1635792T3/pl unknown
- 2004-06-24 ES ES04756130T patent/ES2322854T3/es not_active Expired - Lifetime
- 2004-06-24 WO PCT/US2004/020484 patent/WO2005002548A1/en not_active Ceased
- 2004-06-24 EP EP04756130A patent/EP1635792B1/de not_active Expired - Lifetime
- 2004-06-24 PT PT04756130T patent/PT1635792E/pt unknown
- 2004-06-24 US US10/877,027 patent/US20050069586A1/en not_active Abandoned
- 2004-06-24 DK DK04756130T patent/DK1635792T3/da active
- 2004-06-24 DE DE602004019777T patent/DE602004019777D1/de not_active Expired - Lifetime
- 2004-06-24 AT AT04756130T patent/ATE424192T1/de not_active IP Right Cessation
-
2005
- 2005-12-15 IL IL172602A patent/IL172602A0/en not_active IP Right Cessation
-
2007
- 2007-05-10 US US11/801,777 patent/US20070212409A1/en not_active Abandoned
- 2007-10-26 US US11/977,860 patent/US20080058404A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20080058404A1 (en) | 2008-03-06 |
| IL172602A0 (en) | 2006-04-10 |
| MXPA06000226A (es) | 2006-03-21 |
| WO2005002548A1 (en) | 2005-01-13 |
| EP1635792A1 (de) | 2006-03-22 |
| ES2322854T3 (es) | 2009-06-30 |
| HK1084015A1 (en) | 2006-07-21 |
| PL1635792T3 (pl) | 2009-08-31 |
| EP1635792B1 (de) | 2009-03-04 |
| CA2530788C (en) | 2010-02-09 |
| US20050069586A1 (en) | 2005-03-31 |
| DE602004019777D1 (de) | 2009-04-16 |
| ATE424192T1 (de) | 2009-03-15 |
| PT1635792E (pt) | 2009-05-15 |
| CA2530788A1 (en) | 2005-01-13 |
| US20070212409A1 (en) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06000226A (es) | Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo[3.3..0]-octano-3-carboxilico. | |
| CY1112401T1 (el) | Παραγωγα πυριδαζινης | |
| DE60309829D1 (de) | Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon | |
| DE60133555D1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA200300354A1 (ru) | Хинолиноновые производные в качестве ингибиторов тирозинкиназы | |
| ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| IT1288290B1 (it) | Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie | |
| DK1345611T3 (da) | Antibiotisk/analgetisk formulering og en fremgangsmåde til fremstilling deraf | |
| ID27178A (id) | Senyawa aminosikloheksil eter dan penggunaannya | |
| GEP20105025B (en) | Pharmaceutical compositions for treatent of atherosclerosis and related conditions and use thereof for treatment of these diseases | |
| ATE538797T1 (de) | Pharmazeutische zusammensetzungen mit neuroaktivem steroid und verwendungen davon | |
| DK1446010T3 (da) | Stabiliseret azithromycin-sammensætning | |
| ATE359777T1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| ATE451925T1 (de) | Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung | |
| SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| EE200100487A (et) | Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena | |
| TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| MXPA05013050A (es) | Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos. | |
| GB0118300D0 (en) | Formulations | |
| DE60222131D1 (de) | Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung | |
| SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| UA87146C2 (ru) | Производные диарилметилпиперазина, способ их получения и фармацевтическая композиция на их основе | |
| GB0202635D0 (en) | Formulation containing novel anti-inflammatory androstane derivative |